NDC properties for "tetracaine 2 % Topical Cream" (RxCUI 1733865)
About this data
The tables show NDC propoerties for tetracaine 2 % Topical Cream with the RxCUI 1733865
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tetracaine 2 % Topical Cream (RxCUI 1733865)
| RxCUI | 1733865 |
|---|---|
| SPL_SET_ID | 119ca4c8-b15d-44e6-b0f4-50afaf2c7e59 |
| SPL_SET_ID | 5b56e35b-8a46-4b95-8e7a-4237710efd85 |
| SPL_SET_ID | 9c24dcff-3988-40eb-821a-fd4b0c85f528 |
| SPL_SET_ID | ec6f229a-331e-4b0d-91f1-056eef2eef8b |
| Prescribable Synonym | tetracaine 2 % Topical Cream |
| RXNAV_STR | tetracaine 20 MG/ML Topical Cream |
| RxNorm Name | tetracaine 20 MG/ML Topical Cream |
| RxNorm Synonym | tetracaine 2 % Topical Cream |
| Related queries | Interactions (for RxCUI 1733865) |
NDC Properties
NDC Item 54723001101
| NDC 9 | 54723-011 |
|---|---|
| NDC 10 | 54723-011-01 |
| NDC Item | 54723001101 |
| Packaging | 3 mL in 1 PACKET (54723-011-01) |
| FDA SPL set id | 704771 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
| Related queries | Properties for NDC 9 54723-011 |
NDC Item 54723001401
| NDC 9 | 54723-014 |
|---|---|
| NDC 10 | 54723-014-01 |
| NDC Item | 54723001401 |
| Packaging | 3 mL in 1 PACKET (54723-014-01) |
| FDA SPL set id | 724403 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
| Related queries | Properties for NDC 9 54723-014 |
NDC Item 54723001701
| NDC 9 | 54723-017 |
|---|---|
| NDC 10 | 54723-017-01 |
| NDC Item | 54723001701 |
| Packaging | 3 mL in 1 PACKET (54723-017-01) |
| FDA SPL set id | 785305 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2023-09-26 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |
| Related queries | Properties for NDC 9 54723-017 |
NDC Item 54723001101
| NDC 9 | 54723-011 |
|---|---|
| NDC 10 | 54723-011-01 |
| NDC Item | 54723001101 |
| Packaging | 3 mL in 1 PACKET (54723-011-01) |
| FDA SPL set id | 704771 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
| Related queries | Properties for NDC 9 54723-011 |
NDC Item 54723001401
| NDC 9 | 54723-014 |
|---|---|
| NDC 10 | 54723-014-01 |
| NDC Item | 54723001401 |
| Packaging | 3 mL in 1 PACKET (54723-014-01) |
| FDA SPL set id | 724403 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
| Related queries | Properties for NDC 9 54723-014 |
NDC Item 54723001701
| NDC 9 | 54723-017 |
|---|---|
| NDC 10 | 54723-017-01 |
| NDC Item | 54723001701 |
| Packaging | 3 mL in 1 PACKET (54723-017-01) |
| FDA SPL set id | 785305 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2023-09-26 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |
| Related queries | Properties for NDC 9 54723-017 |
NDC Item 54723001101
| NDC 9 | 54723-011 |
|---|---|
| NDC 10 | 54723-011-01 |
| NDC Item | 54723001101 |
| Packaging | 3 mL in 1 PACKET (54723-011-01) |
| FDA SPL set id | 704771 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
| Related queries | Properties for NDC 9 54723-011 |
NDC Item 54723001401
| NDC 9 | 54723-014 |
|---|---|
| NDC 10 | 54723-014-01 |
| NDC Item | 54723001401 |
| Packaging | 3 mL in 1 PACKET (54723-014-01) |
| FDA SPL set id | 724403 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
| Related queries | Properties for NDC 9 54723-014 |
NDC Item 54723001701
| NDC 9 | 54723-017 |
|---|---|
| NDC 10 | 54723-017-01 |
| NDC Item | 54723001701 |
| Packaging | 3 mL in 1 PACKET (54723-017-01) |
| FDA SPL set id | 785305 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2023-09-26 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |
| Related queries | Properties for NDC 9 54723-017 |